Numerous clinical trials spanning Early Phase 1 through Phase 4 evaluate the therapeutic efficacy and pharmacokinetic profiles of Atorvastatin as both standalone and combination therapies. Covering active, recruiting, completed, and terminated statuses, these studies assess indications such as hypercholesterolemia, coronary artery disease, atherosclerosis, acute coronary syndrome, cerebral infarction, and osteoporosis. Investigations are conducted by major commercial sponsors alongside leading academic institutions.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03819101 | RECRUITING | Prostate Cancer |
Gustave Roussy, Cancer Campus, Grand Paris |
2019-06-06 | PHASE3 |
| NCT05404139 | RECRUITING | Metastatic Prostate Cancer |
University Health Network, Toronto |
2023-05-24 | PHASE2 |
| NCT07586540 | NOT_YET_RECRUITING | Carotid Stenosis |
Middle East North Africa Stroke and Interventional Neurotherapies Organization |
2027-07 | PHASE3 |
| NCT07799779 | NOT_YET_RECRUITING | Acute Coronary Syndromes (ACS) |
Seoul National University Bundang Hospital |
2026-09 | PHASE4 |
| NCT07307989 | RECRUITING | Ischemic Stroke; Hypercholesteremia |
Chang Gung Memorial Hospital |
2025-08-01 | PHASE2 |
| NCT07685938 | NOT_YET_RECRUITING | Chest Wall Tumor; Breast Cancer; Lung Cancer; Esophageal Cancer; Mediastinal Cancers; Spine Metastases; Spinal Tumor; Thoracic Cancer; Thoracic Neoplasms |
UNC Lineberger Comprehensive Cancer Center |
2026-08-12 | PHASE2 |
| NCT06248671 | RECRUITING | Episodic Migraine |
St. Olavs Hospital |
2024-05-01 | PHASE2 |
| NCT06785727 | NOT_YET_RECRUITING | Ischemic Stroke; Transient Ischemic Attack |
Prof. dr. Nathalie van der Velde |
2025-02-01 | PHASE4 |
| NCT07474649 | NOT_YET_RECRUITING | Coronary Atherosclerosis; Mixed Dyslipidemia; Hypercholesterolemia |
Daiichi Sankyo |
2026-08-15 | PHASE3 |
| NCT07568574 | ENROLLING_BY_INVITATION | Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes |
Enhanced Emirates Limited |
2026-03-12 | |
| NCT05796973 | RECRUITING | Prostate Cancer; Breast Cancer; Kidney Cancer; Ovarian Cancer; Metastatic Breast Cancer; Metastatic Kidney Cancer; Metastatic Renal Cell Carcinoma; Metastatic Renal Cancer; Metastatic Prostate Cancer; Metastatic Prostate Adenocarcinoma; Metastatic Ovarian Cancer; Metastatic Ovary Cancer |
Tampere University Hospital |
2023-03-31 | PHASE3 |
| NCT07045142 | RECRUITING | Schizophrenia |
Central South University |
2025-07-01 | PHASE3 |
| NCT07727681 | RECRUITING | Postoperative Atrial Fibrillation; Lung Surgery |
Peking Union Medical College Hospital |
2026-08-01 | PHASE4 |
| NCT07680595 | RECRUITING | Carotid Atherosclerotic Plaque |
Ruijin Hospital |
2026-03-01 | PHASE1; PHASE2 |
| NCT07530640 | RECRUITING | Kawasaki Disease; Coronary Artery Abnormalities |
Children's Hospital of Fudan University |
2026-06-08 | PHASE3 |
| NCT04765137 | RECRUITING | Mild Cognitive Impairment |
Johns Hopkins University |
2021-05-21 | PHASE2 |
| NCT07762105 | NOT_YET_RECRUITING | Thyroid Eye Disease; Graves Ophthalmopathy; Graves Orbitopathy |
Banu Aji Dibyasakti |
2026-08-30 | PHASE1 |
| NCT05641753 | RECRUITING | Type 1 Diabetes |
NYU Langone Health |
2022-12-06 | PHASE4 |
| NCT07634341 | NOT_YET_RECRUITING | Chronic Periodontitis |
Fayoum University |
2026-06 | PHASE4 |
| NCT04735263 | RECRUITING | Age-related Macular Degeneration |
Massachusetts Eye and Ear Infirmary |
2021-02-04 | PHASE2 |
| NCT06785974 | NOT_YET_RECRUITING | Atherosclerosis; Melanoma; Immune-related Adverse Event |
Erasmus Medical Center |
2025-02 | PHASE4 |
| NCT06369571 | ENROLLING_BY_INVITATION | Epilepsy; Dyslipidemia |
Johns Hopkins University |
2024-10-04 | PHASE1; PHASE2 |
| NCT05028829 | RECRUITING | Liver Fibroses; Cirrhosis |
Raymond Chung |
2023-05-10 | PHASE2 |
| NCT04789057 | ACTIVE_NOT_RECRUITING | Copd; COPD Exacerbation; Smoking; Gene Expression; Atorvastatin |
Medical University of Bialystok |
2022-02-11 | PHASE4 |
| NCT03127631 | ACTIVE_NOT_RECRUITING | Prostate Cancer; Cardiovascular Disease |
McMaster University |
2015-10-21 | |
| NCT04262206 | RECRUITING | Cognitive Impairment, Mild; Dementia; Cardiovascular Diseases |
Duke University |
2020-09-01 | PHASE4 |
| NCT07389304 | NOT_YET_RECRUITING | Lipid Profile,Blood Pressure |
Shaheed Benazir Bhutto University Sheringal Dir Upper |
2026-03-01 | PHASE1 |
| NCT06974084 | NOT_YET_RECRUITING | Long COVID |
HealthBio, Inc. |
2026-07-15 | PHASE2; PHASE3 |
| NCT07785934 | RECRUITING | Drug Drug Interaction (DDI); Pharmacokinetics and Pharmacodynamics |
The United Bio-Technology (Hengqin) Co., Ltd. |
2026-05-27 | PHASE1 |
| NCT05589454 | NOT_YET_RECRUITING | Acute Ischemic Stroke; Cerebral Microbleeds |
Sichuan Provincial People's Hospital |
2023-01 | PHASE4 |
| NCT04679376 | ACTIVE_NOT_RECRUITING | NASH - Nonalcoholic Steatohepatitis |
Mayo Clinic |
2023-01-25 | PHASE2 |
| NCT07088250 | RECRUITING | Cerebrovascular Disorders; Intracranial Hemorrhages; Intracranial Hemorrhage; Intracerebral Haemorrhage |
The Second Hospital of Anhui Medical University |
2023-05-06 | |
| NCT05910476 | ACTIVE_NOT_RECRUITING | Coronary Artery Disease; Dyslipidemias |
Yonsei University |
2023-05-03 | PHASE4 |
| NCT07608705 | RECRUITING | Hyperlipidemias |
Shandong Suncadia Medicine Co., Ltd. |
2026-06-08 | PHASE1 |
| NCT02726555 | UNKNOWN | Dyslipidemia; Atherosclerosis |
Wenzhou Medical University |
2015-11 | PHASE3 |
| NCT06750783 | RECRUITING | Prediabetic State (IGT) |
Beijing Tsinghua Chang Gung Hospital |
2024-12-31 | PHASE4 |
| NCT07265466 | RECRUITING | Drug Drug Interaction (DDI) |
Onconic Therapeutics Inc. |
2025-11-17 | PHASE1 |
| NCT06199921 | RECRUITING | Pulmonary Tuberculosis; Tuberculosis; Koch's Disease |
Obafemi Awolowo University Teaching Hospital |
2024-01-03 | PHASE2 |
| NCT07268625 | COMPLETED | Healthy Subjects |
Daiichi Sankyo |
2025-12-09 | PHASE1 |
| NCT06559072 | NOT_YET_RECRUITING | Subarachnoid Hemorrhage; Subarachnoid Hemorrhage, Aneurysmal; Aneurysmal Subarachnoid Hemorrhage; Hemorrhage, Aneurysmal Subarachnoid |
The George Institute |
2024-09-01 | PHASE3 |
| NCT06765265 | RECRUITING | Acute Coronary Syndromes |
King Edward Medical University |
2025-01-05 | PHASE4 |
| NCT06273215 | UNKNOWN | Diabetes |
Peking University Third Hospital |
2023-03-05 | PHASE4 |
| NCT05049603 | NOT_YET_RECRUITING | Graves' Orbitopathy |
University of Pisa |
2024-01-01 | PHASE3 |
| NCT07362030 | ACTIVE_NOT_RECRUITING | Obesity |
Guangdong Raynovent Biotech Co., Ltd |
2025-04-14 | PHASE1 |
| NCT06841536 | COMPLETED | Dyslipidemias |
University of the Faroe Islands |
2025-05-01 | |
| NCT04767984 | ACTIVE_NOT_RECRUITING | Colorectal Carcinoma; Ulcerative Colitis |
Northwestern University |
2021-09-24 | PHASE2 |
| NCT05912686 | UNKNOWN | Mechanical Thrombectomy; Acute Ischemic Stroke |
Zhongda Hospital |
2023-07-01 | PHASE4 |
| NCT02099123 | ACTIVE_NOT_RECRUITING | Independent Living; Disability Free Survival; Elderly; Healthy |
Monash University |
2015-07 | PHASE4 |
| NCT06690164 | RECRUITING | Metabolite |
National University Hospital, Singapore |
2025-06-12 | PHASE4 |
| NCT06948747 | COMPLETED | Healthy Participants |
AstraZeneca |
2025-05-06 | PHASE1 |
| NCT06360120 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2024-04-10 | PHASE3 |
| NCT04379999 | COMPLETED | Lynch Syndrome |
Fox Chase Cancer Center |
2018-09-10 | EARLY_PHASE1 |
| NCT06784557 | RECRUITING | Atherosclerotic Cardiovascular Disease With Dyslipidemia |
Yonsei University |
2024-02-28 | PHASE4 |
| NCT04904536 | ACTIVE_NOT_RECRUITING | Neurocognitive Impairment, Mild |
The George Institute |
2022-03-10 | PHASE3 |
| NCT06723691 | COMPLETED | Type 2 Diabetes |
Fujian Shengdi Pharmaceutical Co., Ltd. |
2024-12-18 | PHASE1 |
| NCT05567068 | COMPLETED | Inflammatory Bowel Diseases |
Tanta University |
2023-02-01 | PHASE2 |
| NCT06976866 | ACTIVE_NOT_RECRUITING | In Recent Years, There Has Been a Rise in the Use of Immediate Loading Protocols; Dental Implant Stability |
Amira attia |
2023-07-13 | |
| NCT06567327 | COMPLETED | Obesity |
Pfizer |
2024-08-28 | PHASE1 |
| NCT06601517 | NOT_YET_RECRUITING | Healthy Adult Subject; Overweight Subject |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
2024-10 | PHASE1 |
| NCT04601116 | RECRUITING | Breast Cancer Female; Estrogen Receptor Positive Tumor |
Aarhus University Hospital |
2021-01-04 | PHASE3 |
| NCT05165251 | UNKNOWN | Isolated Systolic Hypertension |
Shanghai Jiao Tong University School of Medicine |
2022-01-04 | PHASE4 |
| NCT06024096 | COMPLETED | Vaccine Response |
Emory University |
2023-09-20 | PHASE4 |
| NCT05561062 | COMPLETED | Inflammatory Bowel Diseases |
Tanta University |
2022-12-01 | PHASE2 |
| NCT04900155 | UNKNOWN | STEMI; Covid19; NSTEMI |
Penza State University |
2020-11-20 | |
| NCT06871358 | COMPLETED | STEMI (STE-ACS); Primary PCI for STEMI |
Universitas Sebelas Maret |
2024-09-01 | |
| NCT07668076 | COMPLETED | Breast Cancer; Doxorubicin Induced Cardiomyopathy |
Damanhour University |
2022-11-15 | PHASE2 |
| NCT06289504 | COMPLETED | Obesity |
Novo Nordisk A/S |
2024-02-27 | PHASE1 |
| NCT05930028 | COMPLETED | Essential Hypertension; Primary Hypercholesterolemia |
Boryung Pharmaceutical Co., Ltd |
2023-07-13 | PHASE3 |
| NCT02603328 | COMPLETED | Cerebral Cavernous Malformation |
University of Chicago |
2018-07-17 | PHASE1; PHASE2 |
| NCT05845580 | COMPLETED | Drug Adherence |
Lithuanian University of Health Sciences |
2023-06-01 | |
| NCT05747768 | UNKNOWN | Chronic Kidney Disease |
Peking University Third Hospital |
2022-07-15 | PHASE4 |
| NCT07378228 | COMPLETED | Coronary Heart Disease; Stable Angina Pectoris |
Xikun Li |
2023-07-01 | |
| NCT05327595 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2022-05-09 | PHASE1 |
| NCT06293742 | COMPLETED | Type 2 Diabetes Mellitus |
Eccogene |
2024-02-08 | PHASE1 |
| NCT05238012 | COMPLETED | Metabolism Disorder, Lipid; Metabolism Disorder, Glucose |
Heart Health Research Center |
2022-08-02 | PHASE4 |
| NCT04181749 | UNKNOWN | Cardiovascular Risk Factor |
University of Leicester |
2020-11-18 | PHASE2 |
| NCT05790499 | UNKNOWN | Cholesterol Variability; Trained Immunity |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2023-03-20 | |
| NCT06699355 | COMPLETED | Healthy |
Merck Sharp & Dohme LLC |
2023-11-08 | PHASE1 |
| NCT02022293 | SUSPENDED | Nasopharyngeal Carcinoma; Radiation Therapy Complication |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2017-01 | PHASE2 |
| NCT07578857 | COMPLETED | Hyperlipidemias |
Riphah International University |
2023-05-24 | |
| NCT05815680 | COMPLETED | Overweight Subjects; Obese Subjects |
Innovent Biologics (Suzhou) Co. Ltd. |
2023-04-06 | PHASE1 |
| NCT06053983 | COMPLETED | Mi Q Wave |
Rawalpindi Medical College |
2023-01-01 | PHASE4 |
| NCT04685642 | UNKNOWN | Mood Disorder |
Taipei Veterans General Hospital, Taiwan |
2020-08-24 | PHASE4 |
| NCT05839236 | UNKNOWN | COVID-19 Stress Syndrome; COVID-19 Vaccine Adverse Reaction; COVID-19-Associated Thromboembolism; COVID-19 Post-Intensive Care Syndrome; COVID-19-Associated Stroke; COVID-19 Respiratory Infection |
Yang I. Pachankis |
2023-05-01 | PHASE1 |
| NCT02790528 | WITHDRAWN | Angina Pectoris, Variant; Statins, HMG-CoA |
Seung-Jung Park |
2017-07 | PHASE4 |
| NCT05792293 | UNKNOWN | Doxorubicin Induced Cardiomyopathy |
Ain Shams University |
2021-06-01 | PHASE2; PHASE3 |
| NCT05681273 | COMPLETED | T2DM |
Chipscreen Biosciences, Ltd. |
2023-02-17 | PHASE1 |
| NCT04661709 | UNKNOWN | Coronary Heart Disease; Unstable Angina; Chinese Herbal Medicine |
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
2021-03-01 | PHASE4 |
| NCT05679102 | COMPLETED | Atorvastatin Antihypertensive Effect |
Himayat Ullah |
2022-12-20 | |
| NCT07128212 | COMPLETED | Ischemic White Matter Lesions (WMIL); Cerebral Small Vessel Disease; Vascular Cell Adhesion Molecule-1; VCAM-1 |
Suzhou Municipal Hospital of Anhui Province |
2021-01-01 | |
| NCT04945122 | UNKNOWN | Acute Myocardial Infarction; Glucose Metabolism Disorders |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2015-10-01 | PHASE4 |
| NCT05642845 | COMPLETED | Bioequivalence |
Pharmtechnology LLC |
2022-11-19 | PHASE1 |
| NCT04744571 | UNKNOWN | Coronary Artery Disease; Coronary Occlusion; Percutaneous Coronary Intervention; Chronic Total Occlusion of Coronary Artery; Drug-Eluting Stents |
Beijing Anzhen Hospital |
2021-02 | |
| NCT03830164 | COMPLETED | Male Erectile Disorder; Prostate Adenocarcinoma; Erectile Dysfunction, CTCAE; Impotence |
M.D. Anderson Cancer Center |
2019-11-20 | PHASE2 |
| NCT03560882 | ACTIVE_NOT_RECRUITING | Malignant Disease; Solid Tumor; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Cancer; Relapsed Hematologic Malignancy |
Joaquina Baranda |
2018-07-19 | PHASE1 |
| NCT04974814 | UNKNOWN | ST Elevation Myocardial Infarction |
Beni-Suef University |
2021-05-26 | |
| NCT03956368 | UNKNOWN | Chronic Subdural Hematoma |
Chinese University of Hong Kong |
2020-01-09 | PHASE3 |
| NCT02943590 | COMPLETED | Heart Failure |
Massachusetts General Hospital |
2017-01-13 | PHASE2 |
| NCT04072601 | TERMINATED | Liver Cirrhoses |
Copenhagen University Hospital, Hvidovre |
2019-11-08 | PHASE4 |
| NCT05093205 | COMPLETED | Healthy Adults |
Pfizer |
2021-10-25 | PHASE1 |
| NCT03037372 | UNKNOWN | HIV Infection |
Makerere University |
2017-06-01 | PHASE3 |
| NCT05072054 | UNKNOWN | Heart Failure With Reduced Ejection Fraction |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2019-10-16 | PHASE4 |
| NCT05331053 | TERMINATED | Endometriosis |
Penn State University |
2018-05-01 | PHASE4 |
| NCT05730634 | COMPLETED | Diabetes Mellitus, Type 2; Vascular Inflammation |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2019-06-01 | |
| NCT04718155 | COMPLETED | Traumatic Brain Injury |
Assiut University |
2021-03-01 | |
| NCT03943459 | UNKNOWN | Coronary Artery Disease Progression |
InCor Heart Institute |
2019-08-02 | PHASE3 |
| NCT05583643 | COMPLETED | Periodontitis |
Misr University for Science and Technology |
2021-12-07 | PHASE1 |
| NCT04721795 | COMPLETED | Tuberculosis, Pulmonary; Tuberculosis |
Obafemi Awolowo University Teaching Hospital |
2021-01-19 | PHASE2; PHASE3 |
| NCT02740699 | TERMINATED | Cardiovascular Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2016-04-11 | PHASE4 |
| NCT03418974 | UNKNOWN | Dyslipidemias |
Fudan University |
2017-11-01 | PHASE4 |
| NCT04333407 | TERMINATED | COVID-19 |
Imperial College London |
2020-04-03 | |
| NCT04466241 | COMPLETED | COVID-19; COVID-19 Drug Treatment; Severe Acute Respiratory Syndrome Coronavirus 2 |
ANRS, Emerging Infectious Diseases |
2020-11-27 | PHASE2; PHASE3 |
| NCT04251364 | COMPLETED | Hypoxia, Altitude |
Centre d'Expertise sur l'Altitude EXALT |
2020-02-15 | |
| NCT04388501 | COMPLETED | Healthy |
Janssen Pharmaceutica N.V., Belgium |
2021-06-07 | PHASE1 |
| NCT03951207 | COMPLETED | Dyslipidemias; Hypertension |
Yuhan Corporation |
2019-05-30 | PHASE4 |
| NCT01665677 | COMPLETED | Graft vs Host Disease |
Mehdi Hamadani |
2014-01-20 | PHASE2 |
| NCT04270370 | COMPLETED | Healthy |
Eli Lilly and Company |
2020-03-16 | PHASE1 |
| NCT03358017 | COMPLETED | Triple Negative Breast Cancer |
Mario Negri Institute for Pharmacological Research |
2018-03-05 | PHASE2 |
| NCT00911339 | TERMINATED | Stable Coronary Artery Disease |
Fondazione IRCCS Policlinico San Matteo di Pavia |
2009-01 | PHASE3 |
| NCT04472637 | COMPLETED | Arterial Stiffness |
Alexandria University |
2020-11-01 | PHASE2 |
| NCT03110848 | COMPLETED | Thyroid Associated Ophthalmopathy; Hypercholesterolemia |
University of Pisa |
2020-06-01 | PHASE2 |
| NCT04486508 | COMPLETED | Covid19 |
Rajaie Cardiovascular Medical and Research Center |
2020-07-30 | PHASE3 |
| NCT03768427 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2019-05-27 | PHASE3 |
| NCT03510884 | COMPLETED | Hypercholesterolaemia |
Sanofi |
2018-05-31 | PHASE3 |
| NCT04608344 | COMPLETED | Rheumatoid Arthritis |
Gilead Sciences |
2020-11-04 | PHASE1 |
| NCT02863185 | COMPLETED | Chronic Kidney Disease |
Dong-A University |
2016-05-01 | PHASE4 |
| NCT06094244 | COMPLETED | Intracerebral Hemorrhage |
Pomeranian Medical University Szczecin |
2017-03-17 | |
| NCT03275376 | TERMINATED | Overall Survival; Tumor Responses |
Taichung Veterans General Hospital |
2017-12-21 | PHASE2 |
| NCT04453735 | COMPLETED | Statin Adverse Reaction |
Vestre Viken Hospital Trust |
2020-08-19 | PHASE4 |
| NCT03750760 | WITHDRAWN | Myocardial Infarction; Dyslipidemias |
Imperial College London |
2020-01 | PHASE4 |
| NCT03929744 | COMPLETED | Healthy |
Eli Lilly and Company |
2019-06-12 | PHASE1 |
| NCT04306627 | UNKNOWN | Essential Hypertension; Hypercholesterolemia |
Yerevan State Medical University |
2020-04-15 | PHASE4 |
| NCT04151355 | UNKNOWN | Colorectal Cancer |
Ain Shams University |
2019-10-01 | |
| NCT04215237 | UNKNOWN | Atherosclerotic Cardiovascular Disease |
First Affiliated Hospital Xi'an Jiaotong University |
2017-11-13 | |
| NCT04325009 | UNKNOWN | Healthy |
Dong-A ST Co., Ltd. |
2020-03-30 | PHASE1 |
| NCT03066466 | WITHDRAWN | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome |
Loyola University |
2019-12-10 | PHASE3 |
| NCT04047940 | COMPLETED | Healthy |
Eli Lilly and Company |
2019-11-29 | PHASE1 |
| NCT03611010 | COMPLETED | Hypercholesterolemia; Dyslipidemias |
Cumberland Pharmaceuticals |
2018-08-07 | PHASE2 |
| NCT03510715 | COMPLETED | Hypercholesterolemia |
Sanofi |
2018-08-31 | PHASE3 |
| NCT03966859 | COMPLETED | Healthy |
University of Oxford |
2019-06-19 | |
| NCT03122639 | COMPLETED | Obstructive Sleep Apnea of Adult |
Columbia University |
2017-09-01 | EARLY_PHASE1 |
| NCT03874156 | COMPLETED | Statin Adverse Reaction |
Vestre Viken Hospital Trust |
2019-03-05 | PHASE4 |
| NCT02590653 | COMPLETED | Myocardial Infarction |
Penza State University |
2014-10 | PHASE4 |
| NCT03004001 | TERMINATED | Nephrotic Syndrome |
Gloria Vega |
2017-01 | PHASE2 |
| NCT02940366 | UNKNOWN | Metabolic Syndrome |
Seoul National University Hospital |
2016-12-01 | PHASE4 |
| NCT02081638 | COMPLETED | Human Immunodeficiency Virus |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-04-18 | PHASE2 |
| NCT01617772 | UNKNOWN | Non-alcoholic Steatohepatitis |
Tehran University of Medical Sciences |
2016-01-01 | PHASE2 |
| NCT03355027 | UNKNOWN | Atherosclerosis; Cardiovascular Diseases |
Cambridge University Hospitals NHS Foundation Trust |
2017-11-30 | |
| NCT03532620 | UNKNOWN | Prediabetic State; Hypertension; Dyslipidemias |
Jun Tao |
2018-08-09 | PHASE4 |
| NCT02245087 | TERMINATED | Coronary Artery Disease |
University Health Network, Toronto |
2014-08 | PHASE2 |
| NCT03604471 | COMPLETED | Hypercholesterolemia |
Université Catholique de Louvain |
2017-08-08 | PHASE4 |
| NCT02781064 | COMPLETED | Cardiovascular Disease |
London School of Hygiene and Tropical Medicine |
2016-09-01 | PHASE4 |
| NCT05306990 | COMPLETED | Hydroxymethylglutaryl-CoA Reductase Inhibitors; Diabetes Mellitus |
Helwan University |
2017-04-20 | |
| NCT03660293 | COMPLETED | Diabetes Mellitus, Type 1 |
Tanta University |
2017-04-01 | |
| NCT03054467 | UNKNOWN | Quality of Life |
Kosin University Gospel Hospital |
2018-12-01 | PHASE4 |
| NCT02476006 | COMPLETED | Hypercholesterolemia |
Sanofi |
2015-06-23 | PHASE3 |
| NCT04245046 | COMPLETED | Healthy Volunteers |
Midas Pharma GmbH |
2019-01-18 | PHASE1 |
| NCT03760848 | COMPLETED | Healthy |
Galmed Pharmaceuticals Ltd |
2018-11-12 | PHASE1 |
| NCT01674686 | UNKNOWN | Variant Angina |
Samsung Medical Center |
2012-08-01 | PHASE4 |
| NCT03047772 | UNKNOWN | Myocardial Infarction; Stem Cell Transplantation; Angioplasty, Transluminal, Percutaneous Coronary |
Yuejin Yang |
2018-03-06 | PHASE2 |
| NCT03247400 | COMPLETED | Non-segmental Vitiligo |
Nicolaus Copernicus University |
2016-12-01 | PHASE1; PHASE2 |
| NCT03464682 | UNKNOWN | Primary Hypercholesterolemia |
Zhejiang Hisun Pharmaceutical Co. Ltd. |
2015-02-28 | PHASE3 |
| NCT02370784 | COMPLETED | Scleroderma |
Robyn T. Domsic, MD, MPH |
2015-02 | PHASE2 |
| NCT00715273 | COMPLETED | Coronary Artery Disease; Carotid Artery Diseases; Atherosclerosis |
University of Washington |
2001-05-01 | PHASE4 |
| NCT03072082 | UNKNOWN | Coronary Artery Disease(CAD) |
Jun Li |
2017-06 | PHASE4 |
| NCT03801733 | COMPLETED | Drug Interaction Potentiation |
Akebia Therapeutics |
2018-06-17 | PHASE1 |
| NCT01527045 | COMPLETED | Aggressive Non-Hodgkin Lymphoma; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Lymphocytic Leukemia; Loss of Chromosome 17p; Myelodysplastic/Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Aggressive Adult Non-Hodgkin Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Recurrent Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia |
Fred Hutchinson Cancer Center |
2012-09-25 | PHASE2 |
| NCT03311841 | COMPLETED | Renal Insufficiency |
Merck Sharp & Dohme LLC |
2018-03-01 | PHASE1 |
| NCT02984982 | COMPLETED | Hypercholesterolemia; Acute Coronary Syndrome |
Sanofi |
2016-11-15 | PHASE4 |
| NCT02056340 | COMPLETED | Influenza |
Beth Israel Deaconess Medical Center |
2013-10 | PHASE2 |
| NCT02278471 | COMPLETED | Hypertension; Hyperlipidemia |
Vanderbilt University |
2015-12 | PHASE2 |
| NCT02577042 | COMPLETED | Aging-related Inflammation in HIV-infected Patients |
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
2015-10-15 | PHASE4 |
| NCT02674204 | TERMINATED | Breast Cancer; Heart Disease; Cardiotoxicity; Myocardial Dysfunction |
Cedars-Sinai Medical Center |
2016-05-05 | PHASE2 |
| NCT01980823 | COMPLETED | Breast Cancer; Breast Tumors; Cancer of Breast |
Columbia University |
2013-10 | EARLY_PHASE1 |
| NCT02842359 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2016-08-23 | PHASE4 |
| NCT02977065 | COMPLETED | Dyslipidemias |
Chong Kun Dang Pharmaceutical |
2017-03-23 | PHASE2 |
| NCT02364258 | COMPLETED | Dyslipidemia |
Children's Mercy Hospital Kansas City |
2014-07 | PHASE1 |
| NCT02662569 | COMPLETED | Diabetes, Hyperlipidemia, Mixed Dyslipidemia |
Amgen |
2016-04-14 | PHASE3 |
| NCT02452502 | COMPLETED | Stroke |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2015-09-02 | |
| NCT02588235 | UNKNOWN | Coronary Artery Disease |
Xijing Hospital |
2015-10 | PHASE4 |
| NCT01263938 | COMPLETED | HIV Dementia |
University of Pennsylvania |
2011-09 | PHASE4 |
| NCT02791958 | UNKNOWN | Hypertension |
Ferrer Internacional S.A. |
2016-03 | PHASE2 |
| NCT02957162 | COMPLETED | Acute Coronary Syndrome |
University Hospitals of North Midlands NHS Trust |
2016-03 | PHASE4 |
| NCT03461081 | COMPLETED | Hypertension With Hyperlipidemia |
Jeil Pharmaceutical Co., Ltd. |
2017-05-07 | PHASE1 |
| NCT03031119 | COMPLETED | Healthy Volunteers |
Pfizer |
2017-01 | PHASE1 |
| NCT02029534 | UNKNOWN | Cardiothoracic Surgery; Post-operative Atrial Fibrillation |
Creighton University |
2013-08 | PHASE4 |
| NCT02979704 | UNKNOWN | Hyperlipidemia |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2016-09 | PHASE2; PHASE3 |
| NCT03482180 | COMPLETED | Dyslipidemias |
Kuhnil Pharmaceutical Co., Ltd. |
2016-05-04 | PHASE3 |
| NCT03867994 | COMPLETED | Contrast-induced Nephropathy |
rabab ahmed mohamed |
2016-02-01 | PHASE2 |
| NCT01821404 | COMPLETED | Prostatic Neoplasms |
Tampere University Hospital |
2012-08 | PHASE2 |
| NCT02764736 | WITHDRAWN | Complication of Renal Dialysis |
Albert Einstein Healthcare Network |
2016-03-04 | |
| NCT02633956 | COMPLETED | Nonalcoholic Steatohepatitis |
Intercept Pharmaceuticals |
2015-12-04 | PHASE2 |
| NCT03231137 | COMPLETED | Alveolar Socket Preservations |
Ain Shams University |
2012-06-16 | PHASE4 |
| NCT02994745 | COMPLETED | Hypertension, Hyperlipidemia |
Boryung Pharmaceutical Co., Ltd |
2016-12-23 | PHASE1 |
| NCT02910778 | COMPLETED | Ischemia |
Medical University of Vienna |
2016-10 | PHASE4 |
| NCT01528709 | COMPLETED | Saphenous Vein Graft Disease |
Boca Raton Regional Hospital |
2012-03 | PHASE3 |
| NCT02029573 | COMPLETED | Glioblastoma Multiforme |
King Fahad Medical City |
2014-01-01 | PHASE2 |
| NCT01720719 | UNKNOWN | Fatty Liver; Dyslipidemias; Diabetes Mellitus |
Xin Gao |
2013-05 | PHASE4 |
| NCT02522117 | COMPLETED | Renal Insufficiency |
Instituto Mexicano del Seguro Social |
2015-08 | PHASE3 |
| NCT03657472 | COMPLETED | Hypertension; Hyperlipidemia |
HK inno.N Corporation |
2016-09-19 | PHASE1 |
| NCT01956201 | UNKNOWN | Mixed Hyperlipidemia |
Chong Kun Dang Pharmaceutical |
2013-12 | PHASE3 |
| NCT02496962 | UNKNOWN | Sleep Deprivation |
Shi Yang |
2015-07 | |
| NCT01870804 | COMPLETED | Acute Coronary Syndrome |
Centro Cardiopatici Toscani |
2013-05 | PHASE4 |
| NCT02659397 | COMPLETED | Hyperlipidemia |
Esperion Therapeutics, Inc. |
2015-12 | PHASE2 |
| NCT02411903 | UNKNOWN | Cerebral Infarction; Clopidogrel,Poor Metabolism of (Disorder) |
The Third Affiliated Hospital of Guangzhou Medical University |
2015-03 | PHASE4 |
| NCT02550288 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2015-09-29 | PHASE3 |
| NCT02749578 | COMPLETED | Healthy |
Madrigal Pharmaceuticals, Inc. |
2016-04 | PHASE1 |
| NCT01442428 | WITHDRAWN | Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/Aids |
University of Minnesota |
2014-01 | PHASE2; PHASE3 |
| NCT02641899 | COMPLETED | Healthy |
Intarcia Therapeutics |
2015-12 | PHASE1 |
| NCT02609711 | UNKNOWN | Healthy Male Subjects |
Ahn-Gook Pharmaceuticals Co.,Ltd |
2015-11 | PHASE1 |
| NCT02685462 | COMPLETED | Healthy |
Tobira Therapeutics, Inc. |
2016-01-31 | PHASE1 |
| NCT02614352 | UNKNOWN | Healthy Male Subjects |
Ahn-Gook Pharmaceuticals Co.,Ltd |
PHASE1 | |
| NCT02800902 | COMPLETED | Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2015-05 | PHASE2; PHASE3 |
| NCT02380625 | UNKNOWN | Ebola Virus Disease |
Clinical Research Management, Inc. |
2015-04 | PHASE1; PHASE2 |
| NCT02350959 | UNKNOWN | Plaque |
National Health Insurance Service Ilsan Hospital |
2015-01 | PHASE4 |
| NCT02227784 | TERMINATED | Hyperlipidemia |
Eli Lilly and Company |
2014-10 | PHASE3 |
| NCT02114099 | UNKNOWN | Kawasaki Disease; Aneurysm, Coronary |
National Taiwan University Hospital |
2007-06 | PHASE2 |
| NCT02286544 | COMPLETED | Myocardial Infarction; Inflammation; Acute Coronary Syndrome (ACS); Reperfusion Injury |
Karolinska Institutet |
2014-10 | PHASE1 |
| NCT01648829 | UNKNOWN | Coronary Artery Disease |
University of Roma La Sapienza |
2014-01 | PHASE4 |
| NCT01987310 | WITHDRAWN | Non Alcoholic Fatty Liver Disease |
Sheba Medical Center |
2015-12 | |
| NCT01733953 | COMPLETED | Cardiovascular Disease; Childhood ALL; Childhood NHL |
University of Minnesota |
2012-11 | PHASE2 |
| NCT02135029 | COMPLETED | Hyperlipidemia |
Pfizer |
2014-06 | PHASE3 |
| NCT02254824 | UNKNOWN | Hypertension |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2013-10 | PHASE4 |
| NCT01503671 | UNKNOWN | Heart Failure |
National Taiwan University Hospital |
2011-11 | PHASE4 |
| NCT01322711 | UNKNOWN | Type 2 Diabetes Mellitus; Hypercholesterolemia |
University of Roma La Sapienza |
2011-03 | PHASE4 |
| NCT02566187 | COMPLETED | Hypertension; Hyperlipidemia |
Boryung Pharmaceutical Co., Ltd |
2015-08 | PHASE1 |
| NCT01697735 | TERMINATED | Dyslipidemias |
Wenzhou Medical University |
2012-09 | PHASE4 |
| NCT02612792 | COMPLETED | Furcation Defects |
Government Dental College and Research Institute, Bangalore |
2014-12 | PHASE2; PHASE3 |
| NCT01544751 | UNKNOWN | Nonalcoholic Fatty Liver Disease (NAFLD) |
Prof Antonino Belfiore |
2011-09 | |
| NCT01299194 | COMPLETED | BRONCHIECTASIS |
University of Edinburgh |
2010-11 | PHASE4 |
| NCT00979758 | COMPLETED | Myocardial Infarction; Stem Cell Transplantation; Angioplasty, Transluminal, Percutaneous Coronary |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2009-01 | PHASE2 |
| NCT01543555 | COMPLETED | Myocardial Infarction; Peripheral Vascular Disease; Aortic Aneurism |
Hospital do Coracao |
2012-11 | PHASE3 |
| NCT02157337 | COMPLETED | Aortic Surgery; Acute Kidney Injury |
Yonsei University |
2014-03-12 | PHASE4 |
| NCT02600520 | COMPLETED | Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2014-11 | PHASE2; PHASE3 |
| NCT02516111 | COMPLETED | Chronic Periodontitis |
Government Dental College and Research Institute, Bangalore |
2014-09 | PHASE2; PHASE3 |
| NCT02243098 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2014-09-16 | PHASE1 |
| NCT00818103 | UNKNOWN | Multiple Sclerosis |
Sun Yat-sen University |
2006-01 | |
| NCT02055976 | COMPLETED | Hypercholesterolemia |
Pfizer |
2014-03 | PHASE2 |
| NCT01255852 | COMPLETED | CVD |
Jinling Hospital, China |
2011-01 | PHASE4 |
| NCT00663234 | TERMINATED | HIV Infections; Hyperlipidemia |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
2009-08 | PHASE1; PHASE2 |
| NCT01220973 | COMPLETED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2009-02 | PHASE2 |
| NCT00791648 | COMPLETED | Acute Kidney Injury; Post-Operative Delirium; Icu Delirium; Acute Renal Failure; Delirium |
Vanderbilt University Medical Center |
2009-07 | |
| NCT02681653 | COMPLETED | Septic Shock |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2012-01 | |
| NCT03009097 | COMPLETED | Chronic Periaortitis; Intrabony Periodontal Defect |
Kamineni Institute of Dental Sciences |
2013-04 | PHASE4 |
| NCT01780740 | COMPLETED | Disorder; Heart, Functional, Postoperative, Cardiac Surgery; Cardiac Insufficiency Following Cardiac Surgery; Atrial Fibrillation; Ischaemia-reperfusion Injury |
University of Oxford |
2012-01 | PHASE4 |
| NCT01665235 | UNKNOWN | Blood Pressure Variability; Intracranial Artery Stenosis |
RenJi Hospital |
2012-08 | |
| NCT02023892 | UNKNOWN | Endothelium; Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Sun Yat-sen University |
2014-06 | PHASE4 |
| NCT00979940 | TERMINATED | Coronary Artery Disease |
Indiana University |
2008-11 | |
| NCT01544309 | COMPLETED | Hypercholesterolemia With Concomitant Type 2 Diabetes |
Listen Trial Group |
2012-03 | |
| NCT01570530 | TERMINATED | Atrial Fibrillation |
Fundación General Universidad de Valladolid |
2011-01 | PHASE3 |
| NCT01953328 | COMPLETED | Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events |
Amgen |
2013-10 | PHASE3 |
| NCT00805311 | TERMINATED | Carotid Artery Stenosis; Atherosclerosis; Stroke |
Russian Cardiology Research and Production Center |
2009-04 | PHASE4 |
| NCT02113540 | UNKNOWN | Contrast Induced Nephropathy |
Isfahan University of Medical Sciences |
2012-01 | PHASE3 |
| NCT00375518 | COMPLETED | Thoracic Surgery |
Memorial Sloan Kettering Cancer Center |
2006-07 | |
| NCT02089061 | COMPLETED | Acute Coronary Syndromes |
Bristol-Myers Squibb |
2014-03 | PHASE1 |
| NCT00768638 | COMPLETED | Chronic Kidney Disease |
Laval University |
2008-10 | PHASE4 |
| NCT02066207 | COMPLETED | Dyslipidemia (Fredrickson Type Ⅱa); Dyslipidemia (Fredrickson Type Ⅱb) |
Chong Kun Dang Pharmaceutical |
2014-03-18 | PHASE1 |
| NCT02093390 | COMPLETED | Prostate Cancer; Endometriosis |
Millennium Pharmaceuticals, Inc. |
2014-03 | PHASE1 |
| NCT02084069 | COMPLETED | Heart Valve Diseases |
Urmia University of Medical Sciences |
2013-01 | PHASE3 |
| NCT01730040 | COMPLETED | Hypercholesterolemia |
Regeneron Pharmaceuticals |
2012-10 | PHASE3 |
| NCT02080455 | COMPLETED | Effect of Atorvastatin on the Pharmacokinetics of Lomitapide |
Aegerion Pharmaceuticals, Inc. |
2014-01-27 | PHASE1 |
| NCT01043380 | COMPLETED | Hypercholesterolemia; Coronary Artery Disease |
Kumamoto University |
2010-01 | PHASE4 |
| NCT01526460 | COMPLETED | Platelet Dysfunction |
IRCCS San Raffaele |
2011-08 | PHASE2 |
| NCT01929135 | COMPLETED | Chronic Periodontitis |
Universidad de los Andes, Chile |
2013-05 | PHASE2 |
| NCT02225834 | COMPLETED | Ischemic Stroke |
University of Palermo |
2011-11 | PHASE4 |
| NCT00965185 | COMPLETED | Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections |
Massachusetts General Hospital |
2009-09 | |
| NCT01820767 | COMPLETED | Chronic Kidney Disease |
Ricardo Mouzo Mirco |
2012-08 | PHASE3 |
| NCT02432040 | COMPLETED | Psoriasis |
Philippine Dermatological Society |
2013-02 | PHASE2 |
| NCT01236365 | COMPLETED | Diabetes Mellitus, Insulin-Dependent; Hypercholesterolemia |
Nemours Children's Clinic |
2010-10 | PHASE3 |
| NCT00920101 | UNKNOWN | Atherosclerosis; Inflammation |
National Defense Medical College, Japan |
2009-06 | PHASE4 |
| NCT01779453 | COMPLETED | Hypercholesterolemia |
Esperion Therapeutics, Inc. |
2012-12 | PHASE2 |
| NCT01023607 | COMPLETED | Coronary Artery Disease; Hyperlipidemia |
Harbin Medical University |
2009-12 | PHASE4 |
| NCT01071993 | TERMINATED | Nephropathy |
University of Oklahoma |
2010-03 | |
| NCT00292201 | TERMINATED | Asthma |
Queen's University |
2006-02 | PHASE2 |
| NCT01692717 | COMPLETED | Healthy Subjects |
Azidus Brasil |
2013-02-28 | PHASE1 |
| NCT01842256 | COMPLETED | Essential Hypertension; Hyperlipidemia |
Chong Kun Dang Pharmaceutical |
2013-04 | PHASE1 |
| NCT01442987 | COMPLETED | Hypertension; Hyperlipidemia |
Hanmi Pharmaceutical Company Limited |
2011-05 | PHASE3 |
| NCT01795937 | COMPLETED | Healthy |
Boehringer Ingelheim |
2013-02 | PHASE1 |
| NCT01555632 | WITHDRAWN | Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer |
University of Nebraska |
2012-03 | |
| NCT01646307 | UNKNOWN | Focus of Study |
Beijing Anzhen Hospital |
2012-01 | PHASE4 |
| NCT01518231 | UNKNOWN | Stroke |
Zhejiang Hospital |
2012-01 | PHASE1 |
| NCT01765023 | COMPLETED | Healthy |
HK inno.N Corporation |
2012-10 | PHASE1 |
| NCT01806324 | COMPLETED | Hypertension; Hyperlipidemia |
HanAll BioPharma Co., Ltd. |
2012-04 | PHASE1 |
| NCT00185731 | COMPLETED | Leukemia; Lymphoma, Non-Hodgkin |
Dean Felsher |
2005-04 | PHASE2 |
| NCT00917527 | UNKNOWN | Coronary Heart Disease |
Yonsei University |
2009-06 | PHASE4 |
| NCT00637481 | COMPLETED | Atypical Ductal Breast Hyperplasia; Breast Cancer; Ductal Breast Carcinoma in Situ; Lobular Breast Carcinoma in Situ |
National Cancer Institute (NCI) |
2008-03 | PHASE1 |
| NCT01572623 | UNKNOWN | Carotid Stenosis |
Campus Bio-Medico University |
2011-07 | PHASE4 |
| NCT01154036 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2010-07 | PHASE3 |
| NCT00616772 | COMPLETED | Coronary Artery Disease; Coronary Heart Disease; Dyslipidemia |
AbbVie (prior sponsor, Abbott) |
2008-02 | PHASE3 |
| NCT01372839 | UNKNOWN | Myocardial Infarction; Unstable Angina |
Xijing Hospital |
2010-07 | PHASE4 |
| NCT00491751 | TERMINATED | Peripheral Arterial Disease |
Boston University |
2004-05 | PHASE1 |
| NCT01341730 | TERMINATED | Atherosclerosis; Coronary Artery Disease |
The Catholic University of Korea |
2011-06 | PHASE4 |
| NCT01370603 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2011-09 | PHASE3 |
| NCT01350141 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Pfizer |
2011-06 | PHASE2 |
| NCT01386853 | UNKNOWN | Hyperlipidemia |
Tai Tien Pharmaceuticals Co., Ltd. |
2011-07 | PHASE3 |
| NCT01342211 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Pfizer |
2011-07 | PHASE2 |
| NCT00700037 | COMPLETED | Acute Coronary Syndrome; Atherosclerosis; Dyslipidemia |
Wakayama Medical University |
2009-08 | PHASE4 |
| NCT01213498 | COMPLETED | Nephropathy; Cardiovascular Diseases |
Erling Bjerregaard Pedersen |
2010-05 | PHASE2 |
| NCT00490698 | COMPLETED | Kidney Cancer; Renal Cell Carcinoma |
M.D. Anderson Cancer Center |
2006-10 | PHASE2 |
| NCT00579098 | COMPLETED | Atrial Fibrillation; Arrhythmia; Inflammation; Endothelial Dysfunction |
Mayo Clinic |
2007-12 | PHASE4 |
| NCT01288443 | COMPLETED | Hypercholesterolemia |
Sanofi |
2011-01 | PHASE2 |
| NCT01335048 | COMPLETED | Stable Angina |
Ospedale Misericordia e Dolce |
2011-04 | PHASE4 |
| NCT01447797 | COMPLETED | Healthy |
Hanmi Pharmaceutical Company Limited |
2011-09 | PHASE1 |
| NCT01491256 | UNKNOWN | Acute Coronary Syndrome |
The Korean Society of Circulation |
2010-02 | |
| NCT01279590 | COMPLETED | Myalgia; Hypercholesterolemia; Hyperlipidemia |
Furiex Pharmaceuticals, Inc |
2011-03 | PHASE2 |
| NCT01293097 | COMPLETED | Non-ST Segment Elevation Myocardial Infarction; Unstable Angina Pectoris; Stable Angina Pectoris |
Peking University First Hospital |
2010-06 | PHASE4 |
| NCT00965055 | TERMINATED | High Cholesterol; Coronary Artery Disease |
University of California, San Diego |
2009-09 | PHASE3 |
| NCT02292069 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2011-09 | PHASE1 |
| NCT01259284 | TERMINATED | Advanced Cancers |
M.D. Anderson Cancer Center |
2011-01 | PHASE2; PHASE3 |
| NCT01112670 | COMPLETED | Healthy |
University of Colorado, Denver |
2009-11 | PHASE4 |
| NCT01363999 | COMPLETED | Healthy Volunteer |
Hoffmann-La Roche |
2011-06 | PHASE1 |
| NCT01214746 | COMPLETED | Cardiovascular Diseases; Nephropathy |
Regional Hospital Holstebro |
2010-05 | PHASE2 |
| NCT00609063 | COMPLETED | Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases |
Hartford Hospital |
2008-01 | |
| NCT01105975 | COMPLETED | Dyslipidemia |
Eli Lilly and Company |
2010-04 | PHASE2 |
| NCT00620542 | COMPLETED | Coronary Atherosclerosis |
AstraZeneca |
2008-01 | PHASE3 |
| NCT01332747 | COMPLETED | Hyperlipidemia |
Jamia Hamdard University |
2010-05 | PHASE2 |
| NCT00756886 | COMPLETED | Arrhythmia |
University of Alabama at Birmingham |
2008-09 | |
| NCT00862251 | COMPLETED | Cardiovascular Disorder; Diabetes Mellitus |
Organon and Co |
2009-04 | PHASE3 |
| NCT01163851 | COMPLETED | Hypercholesterolemia; Dyslipidemia |
Pfizer |
2010-07 | PHASE1 |
| NCT01072097 | COMPLETED | Polycystic Ovary Syndrome |
University of Oulu |
2006-09 | |
| NCT00331565 | COMPLETED | Morbid Obesity |
University of Oslo School of Pharmacy |
2006-08 | PHASE4 |
| NCT00914017 | UNKNOWN | Breast Cancer |
University of Vermont |
2005-01 | PHASE2 |
| NCT00664846 | COMPLETED | Stroke |
Peking Union Medical College Hospital |
2008-04 | |
| NCT00143741 | COMPLETED | End-Stage Kidney Disease |
University of Chicago |
2005-05 | PHASE1 |
| NCT00701220 | COMPLETED | Cardiovascular Disease; Cardiomyopathy; Heart Disease; Myocardial Disease; Myocardial Ischemia |
Philip Binkley |
2007-04 | PHASE4 |
| NCT00723320 | UNKNOWN | Atherosclerosis |
Ministry of Science and Technology of the People´s Republic of China |
2008-02 | |
| NCT00153166 | COMPLETED | Arterial Occlusive Disease; Intermittent Claudication; Insulin Resistance |
Brigham and Women's Hospital |
2004-01 | PHASE2; PHASE3 |
| NCT01059864 | COMPLETED | Rheumatoid Arthritis |
Pfizer |
2010-02 | PHASE2 |
| NCT00289900 | COMPLETED | Mixed Hyperlipidemia |
Merck Sharp & Dohme LLC |
2006-01-24 | PHASE3 |
| NCT00529542 | COMPLETED | Polycystic Ovary Syndrome |
Milton S. Hershey Medical Center |
2004-12 | PHASE2 |
| NCT00910221 | COMPLETED | Acute Kidney Dysfunction |
Austin Health |
2008-03 | PHASE2; PHASE3 |
| NCT01138072 | COMPLETED | Infection, Human Immunodeficiency Virus |
GlaxoSmithKline |
2010-06 | PHASE1 |
| NCT01096875 | COMPLETED | Coronary Artery Bypass Surgery; Elective Surgical Procedure |
Ankara University |
2010-02 | PHASE4 |
| NCT01257009 | COMPLETED | Stable Chronic Kidney Disease; Hypertension |
UMC Utrecht |
2009-08 | PHASE4 |
| NCT01050348 | COMPLETED | Acute Myocardial Infarction |
The Western Pennsylvania Hospital |
2009-06 | PHASE4 |
| NCT01058057 | UNKNOWN | Coronary Artery Disease; Coronary Angioplasty |
University Hospital, Motol |
2008-02 | PHASE3 |
| NCT00772564 | COMPLETED | Myocardial Infarction |
Rambam Health Care Campus |
2008-08 | PHASE4 |
| NCT01115985 | COMPLETED | Healthy; Pharmacokinetics of Atorvastatin |
Astellas Pharma Inc |
2010-03 | PHASE1 |
| NCT01111656 | COMPLETED | Relapsing-remitting Multiple Sclerosis |
Insel Gruppe AG, University Hospital Bern |
2007-03 | PHASE2 |
| NCT00615823 | COMPLETED | Hypertension, Pulmonary |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2007-02 | PHASE2 |
| NCT01299597 | COMPLETED | Sleep Disorders |
GlaxoSmithKline |
2010-01-18 | PHASE1 |
| NCT00987974 | COMPLETED | Ischemia Reperfusion Injury; Endothelial Dysfunction |
Radboud University Medical Center |
2009-09 | PHASE4 |
| NCT00065806 | COMPLETED | Lupus Erythematosus, Systemic |
Laura Schanberg |
2003-09 | PHASE3 |
| NCT00703261 | COMPLETED | Atherosclerotic Vascular Disease |
Merck Sharp & Dohme LLC |
2008-08 | PHASE1 |
| NCT00902967 | UNKNOWN | Abdominal Surgery |
B. J. Medical College, Pune |
2009-07 | PHASE3 |
| NCT00620204 | UNKNOWN | Angina Pectoris, Variant |
Samsung Medical Center |
2008-01 | PHASE4 |
| NCT01200056 | COMPLETED | Coronary Disease; Ultrasonography, Interventional; Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Prof. Stephen Lee |
2007-08 | PHASE4 |
| NCT00640744 | UNKNOWN | Atherosclerosis |
Baylor College of Medicine |
2006-02 | PHASE4 |
| NCT00718796 | COMPLETED | Cardiovascular Disease |
The Canadian College of Naturopathic Medicine |
2008-04 | PHASE3 |
| NCT01499758 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2009-10 | PHASE1 |
| NCT01073800 | COMPLETED | Myocardial Infarction; Stroke; Renal Failure |
University of Alberta |
2009-04 | PHASE2; PHASE3 |
| NCT00404599 | UNKNOWN | Diabetes Mellitus; Hypertension |
Amsterdam UMC, location VUmc |
2007-02 | PHASE4 |
| NCT01285544 | COMPLETED | Dyslipidemia; Cardiovascular Disease; Hypercholesterolemia |
Seoul National University Hospital |
2008-09 | PHASE4 |
| NCT00463827 | COMPLETED | Asthma; COPD; Smoking |
NHS Greater Clyde and Glasgow |
2007-08 | PHASE2 |
| NCT00889226 | COMPLETED | Hypercholesterolemia With Type2DM |
JW Pharmaceutical |
2008-04 | PHASE4 |
| NCT00094172 | COMPLETED | Multiple Sclerosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2005-05 | PHASE2 |
| NCT00739999 | COMPLETED | Pediatric Heterozygous Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2008-12 | PHASE1 |
| NCT01645410 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2009-03 | PHASE1 |
| NCT00335504 | COMPLETED | Colon Cancer; Precancerous Condition; Rectal Cancer |
National Cancer Institute (NCI) |
2006-03 | PHASE2 |
| NCT00734123 | UNKNOWN | Atherosclerosis; Cardiovascular Diseases |
Hospital Arnau de Vilanova |
2008-04 | PHASE4 |
| NCT00960323 | COMPLETED | Healthy |
Mutual Pharmaceutical Company, Inc. |
2009-02 | PHASE1 |
| NCT01041729 | COMPLETED | Peripheral Arterial Disease |
Hospital Universitario Getafe |
2008-01 | PHASE4 |
| NCT00535405 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-11 | PHASE3 |
| NCT00491400 | TERMINATED | Diabetes Mellitus; Metabolic Syndrome |
Boston University |
2005-09 | |
| NCT00172419 | COMPLETED | Hyperlipidemia |
National Taiwan University Hospital |
2007-03 | |
| NCT00361283 | COMPLETED | Inflammation |
University of Florida |
2004-06 | PHASE4 |
| NCT00728013 | UNKNOWN | Acute Coronary Syndrome |
Ministry of Science and Technology of the People´s Republic of China |
2006-12 | |
| NCT00808717 | COMPLETED | Myocardial Infarction; Angioplasty; Percutaneous Coronary |
Yonsei University |
2007-07 | PHASE4 |
| NCT00491530 | COMPLETED | Mixed Dyslipidemia |
Abbott |
2007-06 | PHASE3 |
| NCT00252967 | TERMINATED | Atrial Fibrillation; Inflammation |
Emory University |
2005-10 | PHASE3 |
| NCT01029522 | COMPLETED | Dyslipidemia |
Chong Kun Dang Pharmaceutical |
2008-08 | PHASE4 |
| NCT00344019 | TERMINATED | Coronary Disease |
Beth Israel Deaconess Medical Center |
2006-05 | PHASE4 |
| NCT00559962 | COMPLETED | Hyperlipidemia |
Aegerion Pharmaceuticals, Inc. |
2007-10 | PHASE2 |
| NCT00442897 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2006-09 | PHASE4 |
| NCT00627575 | COMPLETED | Epilepsy |
GlaxoSmithKline |
2008-02-04 | PHASE1 |
| NCT00917579 | COMPLETED | Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2008-07 | PHASE4 |
| NCT00610545 | COMPLETED | Vascular Surgery |
University of Campinas, Brazil |
2007-07 | PHASE4 |
| NCT00496730 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2007-07 | PHASE3 |
| NCT00362934 | COMPLETED | Hyperlipidemia |
Solvay Pharmaceuticals |
2006-10 | PHASE3 |
| NCT00701883 | COMPLETED | Hyperlipidemia |
Gilead Sciences |
2007-08 | PHASE2 |
| NCT00716846 | COMPLETED | Healthy Volunteers |
Hamamatsu University |
2006-06 | |
| NCT00505336 | COMPLETED | Diastolic Heart Failure |
St Vincent's University Hospital, Ireland |
2006-04 | |
| NCT00367458 | COMPLETED | HIV |
National Institute of Allergy and Infectious Diseases (NIAID) |
2006-10-18 | PHASE2 |
| NCT00585611 | TERMINATED | Diastolic Heart Failure |
University of Wisconsin, Madison |
2005-12 | |
| NCT01062802 | COMPLETED | Abdominal Aortic Aneurysm |
University of Hull |
2005-01 | PHASE4 |
| NCT00395486 | COMPLETED | Metabolic Syndrome X |
AstraZeneca |
2006-09 | PHASE4 |
| NCT00540293 | COMPLETED | Dyslipidemias |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2007-10 | PHASE4 |
| NCT00678522 | COMPLETED | Healthy Subjects |
Regional Hospital Holstebro |
2007-09 | PHASE4 |
| NCT00412113 | COMPLETED | Dyslipidemia; Hypertension |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2007-01 | PHASE4 |
| NCT00530946 | COMPLETED | Hypertension; Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2007-09 | PHASE3 |
| NCT00344370 | COMPLETED | Type II Diabetes Mellitus; Dyslipidemia |
Kowa Research Europe |
2006-08 | PHASE3 |
| NCT00494663 | TERMINATED | Type 2 Diabetes |
DiObex |
2007-07 | PHASE2 |
| NCT00770796 | COMPLETED | Contrast Induced Nephropathy |
Ospedale Misericordia e Dolce |
2006-04 | PHASE4 |
| NCT00300430 | COMPLETED | Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia |
Abbott |
2006-09 | PHASE3 |
| NCT00276484 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2006-02 | PHASE3 |
| NCT00286312 | COMPLETED | Myocardial Infarction; Reperfusion Injury |
R&D Cardiologie |
2006-02 | PHASE4 |
| NCT00504829 | COMPLETED | Dyslipidemia |
Veloxis Pharmaceuticals |
2007-07 | PHASE2 |
| NCT00427960 | TERMINATED | Hypercholesterolaemia |
AstraZeneca |
2006-12 | PHASE4 |
| NCT00465088 | COMPLETED | Hyperlipidemia; Mixed Dyslipidemia |
Abbott |
2007-04 | PHASE3 |
| NCT00536887 | COMPLETED | Acute Myocardial Infarction |
Korea University Anam Hospital |
2005-07 | PHASE4 |
| NCT00412841 | TERMINATED | Avascular Necrosis |
NYU Langone Health |
2002-11 | PHASE2 |
| NCT00974740 | TERMINATED | Type 1 Diabetes |
Profil Institut für Stoffwechselforschung GmbH |
2004-03 | PHASE1 |
| NCT00276458 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2006-02 | PHASE3 |
| NCT00359281 | COMPLETED | Healthy |
Aegerion Pharmaceuticals, Inc. |
2006-03 | PHASE2 |
| NCT00166504 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-10 | PHASE4 |
| NCT00435045 | COMPLETED | Hypertriglyceridemia |
GlaxoSmithKline |
2007-02 | PHASE3 |
| NCT00157924 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-11 | PHASE4 |
| NCT00126048 | COMPLETED | Asthma |
University of Glasgow |
2005-07 | PHASE2; PHASE3 |
| NCT00072826 | COMPLETED | Sickle Cell Disease |
National Institutes of Health Clinical Center (CC) |
2003-11-04 | PHASE1 |
| NCT00214630 | COMPLETED | Acute Coronary Syndromes |
AstraZeneca |
2003-12 | PHASE3 |
| NCT00652327 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-12 | PHASE4 |
| NCT00132717 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2005-01-01 | PHASE3 |
| NCT00395603 | TERMINATED | Cardiovascular Diseases; Diabetes Mellitus |
Organon and Co |
2006-09 | PHASE3 |
| NCT00616187 | COMPLETED | Relapsing Remitting Multiple Sclerosis |
Charite University, Berlin, Germany |
2003-10 | PHASE2 |
| NCT00134264 | TERMINATED | Coronary Disease; Diabetes Mellitus |
Pfizer |
2004-07 | PHASE3 |
| NCT00309751 | COMPLETED | Type II Diabetes Mellitus; Dyslipidemia |
Kowa Research Europe |
2005-12 | PHASE3 |
| NCT00487994 | COMPLETED | Dyslipidemia |
Takeda |
2004-11 | PHASE3 |
| NCT00751907 | COMPLETED | Alzheimer's Disease |
University of Wisconsin, Madison |
2006-06 | PHASE2 |
| NCT01187992 | TERMINATED | Acute Coronary Syndrome; Coronary Artery Disease |
San Filippo Neri General Hospital |
2003-09 | PHASE3 |
| NCT00134550 | COMPLETED | Foot Ulcer; Diabetes |
Asker & Baerum Hospital |
2005-02 | PHASE2 |
| NCT00166530 | COMPLETED | Atherosclerosis |
Organon and Co |
2005-11 | PHASE4 |
| NCT00300469 | COMPLETED | Mixed Dyslipidemia; Coronary Heart Disease; Dyslipidemia |
Abbott |
2006-03 | PHASE3 |
| NCT00411190 | COMPLETED | Osteoarthritis |
GlaxoSmithKline |
2006-10-19 | PHASE1 |
| NCT00355251 | TERMINATED | HIV Infections |
Germans Trias i Pujol Hospital |
2006-07 | PHASE4 |
| NCT00267280 | TERMINATED | Hyperlipidemia; Dyslipidemia; Hypercholesterolemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00202904 | COMPLETED | Hypercholesterolemia; Coronary Heart Disease |
Organon and Co |
2005-05 | PHASE4 |
| NCT00770575 | COMPLETED | Cardiovascular Diseases |
Takeda |
2005-06 | PHASE2 |
| NCT00319449 | COMPLETED | Hypercholesterolemia; Coronary Arteriosclerosis |
Organon and Co |
2005-09 | PHASE4 |
| NCT00138762 | COMPLETED | Hyperlipidemia |
Pfizer |
2004-07 | PHASE3 |
| NCT00194402 | COMPLETED | Dyslipidemia |
University of Washington |
2003-08 | PHASE4 |
| NCT00110435 | COMPLETED | Type 2 Diabetes Mellitus; Hypercholesterolemia |
Organon and Co |
2005-05 | PHASE3 |
| NCT00241488 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2003-06 | PHASE3 |
| NCT00345202 | COMPLETED | Healthy |
Regional Hospital Holstebro |
2004-09 | PHASE4 |
| NCT00239330 | COMPLETED | Hypercholesteremia |
AstraZeneca |
2003-06 | PHASE3 |
| NCT00651404 | COMPLETED | Hypercholesterolemia; Atherosclerosis |
Organon and Co |
2004-01 | PHASE3 |
| NCT00090168 | COMPLETED | Hypercholesterolemia; Atherosclerotic Disease; Coronary Disease |
Organon and Co |
2004-01-27 | PHASE3 |
| NCT03882996 | COMPLETED | Hypercholesterolemia |
Organon and Co |
2000-10-06 | PHASE3 |
| NCT00632840 | COMPLETED | Obesity; Lipid Disorders; Hypertriglyceridemia; Cardiovascular Disease |
The University of Western Australia |
2001-06 | PHASE4 |
| NCT02587416 | COMPLETED | Hypercholesteremia |
NeuroBo Pharmaceuticals Inc. |
2002-11 | PHASE1 |
| NCT03884452 | COMPLETED | Familial Hypercholesterolemia |
Organon and Co |
2000-05-03 | PHASE3 |
| NCT00267254 | COMPLETED | Hyperlipidemia; Dyslipidemia; Hypercholesterolemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00139061 | COMPLETED | Hyperlipidemia |
Pfizer |
2005-03 | PHASE3 |
| NCT01053065 | COMPLETED | Symptomatic Carotid Stenosis; Hypercholesterolemia; Indication for Carotid Endarterectomy |
University of Padova |
||
| NCT00134173 | COMPLETED | Coronary Disease; Coronary Arteriosclerosis; Hyperlipidemia |
Pfizer |
2003-10 | PHASE3 |
| NCT00000941 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00653965 | COMPLETED | Hypercholesterolemia; Dyslipidaemia |
AstraZeneca |
2003-05 | PHASE3 |
| NCT00134498 | COMPLETED | Hypertriglyceridemia; Hyperlipoproteinemia Type IV |
Pfizer |
2005-02 | PHASE3 |
| NCT00433823 | UNKNOWN | Coronary Heart Disease; Diabetes Mellitus; Non-Coronary Atherosclerotic Disease; Hypercholesterolemia |
Abant Izzet Baysal University |
2007-01 | PHASE4 |
| NCT00654537 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2001-04 | PHASE3 |
| NCT00572312 | COMPLETED | Chronic Kidney Disease; Proteinuria |
Medical University of Gdansk |
2005-02 | |
| NCT00004564 | UNKNOWN | Hypercholesterolemia; Thrombosis |
National Center for Research Resources (NCRR) |
||
| NCT00403533 | COMPLETED | Hepatitis C |
Massachusetts General Hospital |
2006-02 | PHASE2 |
| NCT00408382 | COMPLETED | Hypercholesteremia; Coronary Artery Disease |
Astellas Pharma Inc |
PHASE4 | |
| NCT00654485 | COMPLETED | Metabolic Syndrome |
AstraZeneca |
2002-05 | PHASE3 |
| NCT00449410 | COMPLETED | Atrial Fibrillation; Neuropsychology; Magnetic Resonance Imaging; Inflammation; Hemostasis |
Radboud University Medical Center |
2005-05 | PHASE4 |
| NCT00147602 | COMPLETED | Cardiovascular Disease |
Pfizer |
1998-11 | PHASE4 |
| NCT00150371 | COMPLETED | Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-06 | PHASE3 |
| NCT00150384 | COMPLETED | Hypertension; Dyslipidemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2004-07 | PHASE4 |
| NCT00115830 | COMPLETED | Atherosclerosis |
Brigham and Women's Hospital |
2004-12 | PHASE3 |
| NCT00079638 | COMPLETED | Dyslipidemia; Coronary Heart Disease; Atherosclerosis; Stroke; Diabetes |
Kos Pharmaceuticals |
2004-04 | PHASE4 |
| NCT00457340 | COMPLETED | Arrhythmia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2000-02 | PHASE4 |
| NCT00522158 | COMPLETED | Type 2 Diabetes Mellitus; Cardiovascular Disease; LDL Cholesterol; Cognition |
Baskent University |
PHASE4 | |
| NCT00267267 | TERMINATED | Hyperlipidemia; Dyslipidemia |
Pfizer |
2006-01 | PHASE3 |
| NCT00380939 | COMPLETED | Coronary Arteriosclerosis |
Pfizer |
1999-04 | PHASE4 |
| NCT00024531 | COMPLETED | Alzheimer Disease |
Institute for the Study of Aging (ISOA) |
2000-10 | PHASE2 |
| NCT00136942 | COMPLETED | Hyperlipidemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2005-04 | PHASE3 |
| NCT00151502 | COMPLETED | Alzheimer's Disease |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2002-11 | PHASE3 |
| NCT00164086 | UNKNOWN | Myeloma |
Bayside Health |
PHASE1 | |
| NCT00124397 | COMPLETED | Type 2 Diabetes Mellitus |
University of Southern Denmark |
2001-07 | PHASE4 |
| NCT00388596 | COMPLETED | Osteoporosis |
GlaxoSmithKline |
2006-10 | PHASE1 |
| NCT00201552 | UNKNOWN | Paroxysmal Atrial Fibrillation |
National Taiwan University Hospital |
||
| NCT00163202 | COMPLETED | Coronary Arteriosclerosis; Hypercholesterolemia |
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
2002-06 | PHASE4 |
| NCT00653588 | COMPLETED | Hypercholesterolemia; Coronary Heart Disease |
AstraZeneca |
2003-04 | PHASE3 |
| NCT00115817 | COMPLETED | Atherosclerosis |
Brigham and Women's Hospital |
2005-06 | PHASE3 |
| NCT00432354 | UNKNOWN | Systemic Lupus Erythematosus |
Buddhist Tzu Chi General Hospital |
2007-03 | PHASE2; PHASE3 |
| NCT00335699 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2005-08 | PHASE4 |
| NCT00497016 | COMPLETED | Hypertension |
Radboud University Medical Center |
2007-05 | |
| NCT00120133 | COMPLETED | Osteoporosis |
Children's Mercy Hospital Kansas City |
2004-12 | |
| NCT00103974 | COMPLETED | Multiple Sclerosis |
Bayhill Therapeutics |
2004-07 | PHASE1 |
| NCT00654407 | COMPLETED | Hypercholesterolemia |
AstraZeneca |
2001-11 | PHASE3 |
| NCT00327691 | COMPLETED | Cardiovascular Disease; Cerebrovascular Accident; Coronary Heart Disease |
Pfizer |
1998-04 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-05-06)
Check the
Atorvastatin
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.